# Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)

> **NCT03263962** · — · COMPLETED · sponsor: **University of Pavia** · enrollment: 502 (actual)

## Conditions studied

- Cardiac Heart Failure Patients

## Interventions

- **DRUG:** Canrenone

## Key facts

- **NCT ID:** NCT03263962
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-13
- **Primary completion:** 2017-09-10
- **Final completion:** 2017-11-30
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03263962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03263962, "Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03263962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*